Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression-Reference-Cited by-同舟云学术

Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression

Published:2013-02 Issue:2 Volume:137 Page:153-171
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Lee Jong Hun,Khor Tin Oo,Shu Limin,Su Zheng-Yuan,Fuentes Francisco,Kong Ah-Ng Tony

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference298 articles.

1. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation;Afshari;Cancer Res,1999

2. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?;Aggarwal;Ann N Y Acad Sci,2009

3. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor;Alam;J Biol Chem,2000

4. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc Natl Acad Sci U S A,2003

5. Death receptors: signaling and modulation;Ashkenazi;Science,1998

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Yunnan edible flowers and their potential in future foods: focus on ethnological applications, chemical and pharmacological research;Journal of Future Foods;2025-06

2. Serving up health: How phytochemicals transform food into medicine in the battle against cancer;Food Frontiers;2024-07-07

3. Exploring the therapeutic potential of bioactive compounds derived from Artemisia absinthium against breast cancer cell line;PAK J PHARM SCI;2024

4. Exploring the therapeutic potential of bioactive compounds derived from Artemisia absinthium against breast cancer cell line;PAK J PHARM SCI;2024

5. Novel inhaled andrographolide for treatment of lung cancer: In vitro assessment;Heliyon;2024-05